ABEO
ABEONA THERAPEUTICS INC.
Key Financials
Revenue
$5.8M
↑ 66.3%
Operating Income
$-89448000
↓ 39.3%
Total Assets
$219.6M
↑ 101.6%
Shareholders' Equity
$159.2M
↑ 261.6%
EPS (Diluted)
$1.01
↑ 165.2%
Total Liabilities
$60.4M
↓ 7.0%
Cash & Equivalents
$78.4M
↑ 235.8%
Net Income
$71.2M
↑ 211.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 9/29/2026 | View on SEC |
| 4 | 9/29/2026 | View on SEC |
| 4 | 9/29/2026 | View on SEC |
| 4 | 9/29/2026 | View on SEC |
| 144 | 9/29/2026 | View on SEC |
| 144 | 9/29/2026 | View on SEC |
| 144 | 9/29/2026 | View on SEC |
| 144 | 9/29/2026 | View on SEC |
| 8-K | 9/15/2026 | View on SEC |
| 4 | 9/1/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ABEO |
| Company Name | ABEONA THERAPEUTICS INC. |
| CIK | 318306 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 646-813-4701 |